| Autor: |
Alexander, James L, Liu, Zhigang, Muñoz Sandoval, Diana, Reynolds, Catherine, Ibraheim, Hajir, Anandabaskaran, Sulak, Saifuddin, Aamir, Castro Seoane, Rocio, Anand, Nikhil, Nice, Rachel, Bewshea, Claire, D'Mello, Andrea, Constable, Laura, Jones, Gareth R, Balarajah, Sharmili, Fiorentino, Francesca, Sebastian, Shaji, Irving, Peter M, Hicks, Lucy C, Williams, Horace R T, Kent, Alexandra J, Linger, Rachel, Parkes, Miles, Kok, Klaartje, Patel, Kamal V, Teare, Julian P, Altmann, Daniel M, Goodhand, James R, Hart, Ailsa L, Lees, Charlie W, Boyton, Rosemary J, Kennedy, Nicholas A, Ahmad, Tariq, Powell, Nick, Chukwurah, Ijeoma, Haq, Sulaimaan, Shah, Parita, Wilken-Smith, Stephanie, Ramanathan, Anitha, Patel, Mikin, Romanczuk, Lidia, King, Rebecca, Domingo, Jason, Shamtally, Djamila, Mendoza, Vivien, Sanchez, Joanne, Stark, Hannah, Knight, Bridget, Bee, Louise, Estember, Charmaine, Barnes, Anna, Watkins, Darcy, Stone, Sam, Kirkwood, John, Parkinson, Marian, Gardner-Thorpe, Helen, Covil, Kate, Derikx, Lauranne, Gros Alcalde, Beatriz, Lee, Irish, Cipriano, Bessie, Ruocco, Giuseppe, Baden, Manisha, Cooke, Graham, Pollock, Katrina, Kourampa, Evgenia, Pasquale, Ciro, Robisco-Diaz, Elena, Bhatti, Suhaylah |
| Zdroj: |
The Lancet Gastroenterology & Hepatology; November 2022, Vol. 7 Issue: 11 p1005-1015, 11p |
| Abstrakt: |
COVID-19 vaccine-induced antibody responses are reduced in patients with inflammatory bowel disease (IBD) taking anti-TNF or tofacitinib after two vaccine doses. We sought to assess whether immunosuppressive treatments were associated with reduced antibody and T-cell responses in patients with IBD after a third vaccine dose. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
